FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 3922661 · Received July 9, 2014

Report

Report Number
1030489-2014-03162
Event Type
Injury
Date Received
July 9, 2014
Report Date
July 6, 2015
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(6). (B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT PRESENTED WITH PAIN IN HIS LOWER BACK AND LEG. (B)(6) 2010: THE PATIENT UNDERWENT A LUMBAR FUSION SURGERY WHERE RHBMP-2/ACS WAS IMPLANTED. IT WAS REPORTED THAT THE PATIENT FELL AND WAS TOLD HE WOULD REQUIRE NECK SURGERY TO CORRECT HIS NECK. (B)(6) 2010: THE PATIENT UNDERWENT A CERVICAL FUSION SURGERY WHERE RHBMP-2/ACS IMPLANTED. (B)(6) 2011: THE PATIENT UNDERWENT A LUMBAR FUSION SURGERY. THE PATIENT NOW EXPERIENCES PAIN IN HIS LEGS, ARMS, HANDS, FEET AND IN HIS LOWER BACK. THE PATIENT NOW REQUIRES NARCOTICS TO FUNCTION AND MUST WALK WITH A CANE. THE PATIENT'S POSTOPERATIVE PERIOD WAS MARKED BY PAIN. IMAGING STUDIES SHOWED THAT THE PATIENT HAD DEVELOPED UNCONTROLLED BONE GROWTH AND RESULTING NERVE IMPINGEMENT AT THE SITE OF IMPLANT. THE PATIENT CONTINUES TO HAVE BONE OVERGROWTH CAUSING NERVE IMPINGEMENT, AND CHRONIC PAIN.

Description of Event or Problem · 1

THE PATIENT WAS IMPLANTED WITH RHBMP-2/ACS IN THE SURGERY OF (B)(6) 2011.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
401103 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention